PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicenter real-world cohort

MLA

Bernhard Scheiner, et al. “PD-1 Targeted Immunotherapy in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-World Cohort.” Zeitschrift Für Gastroenterologie, May 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2cc19e07fdd34f50bb42b0278e1c6a0b&authtype=sso&custid=ns315887.

APA

Bernhard Scheiner, F. Hucke, Fabian Finkelmeier, Joerg Trojan, Thomas Reiberger, Fredrik Waneck, Matthias Pinter, M. Trauner, J von Felden, Kornelius Schulze, Philipp Schwabl, Sandra Koch, Arndt Vogel, Markus Peck-Radosavljevic, Oliver Waidmann, Martha M. Kirstein, Christian Müller, Wolfgang Sieghart, Jan B. Hinrichs, … Henning Wege. (2019). PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicenter real-world cohort. Zeitschrift Für Gastroenterologie.

Chicago

Bernhard Scheiner, F. Hucke, Fabian Finkelmeier, Joerg Trojan, Thomas Reiberger, Fredrik Waneck, Matthias Pinter, et al. 2019. “PD-1 Targeted Immunotherapy in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-World Cohort.” Zeitschrift Für Gastroenterologie, May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2cc19e07fdd34f50bb42b0278e1c6a0b&authtype=sso&custid=ns315887.